Dr. Charu Aggarwal from University of Pennsylvania Abramson Cancer Center joins Dr. Jack West to discuss new data on plasma-based testing for tumor mutational burden (TMB) & the current state of liquid biopsies, TMB, & immunotherapy-based options today. (36:57)
Dr. Charu Aggarwal discusses with Dr. West how she and her colleagues at Univ. of Pennsylvania can develop their own careers alongside each other, #medTwitter, how she navigates work-life balance, & the improving support for women in heme/onc. (16:01)
Dr. West & Charu Aggarwal from University of Pennsylvania reviews data from her own group & other centers, demonstrating increasing practical utility & remaining limitations of liquid biopsy testing for molecular markers in advanced NSCLC. (26:52)
Drs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported. (19:05)
